These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A preliminary attempt to visualize nigrosome 1 in the substantia nigra for Parkinson's disease at 3T: An efficient susceptibility map-weighted imaging (SMWI) with quantitative susceptibility mapping using deep neural network (QSMnet). Jo M; Oh SH Med Phys; 2020 Mar; 47(3):1151-1160. PubMed ID: 31883389 [TBL] [Abstract][Full Text] [Related]
3. Imaging of nigrosome 1 in substantia nigra at 3T using multiecho susceptibility map-weighted imaging (SMWI). Nam Y; Gho SM; Kim DH; Kim EY; Lee J J Magn Reson Imaging; 2017 Aug; 46(2):528-536. PubMed ID: 27859983 [TBL] [Abstract][Full Text] [Related]
4. Imaging the Nigrosome 1 in the substantia nigra using susceptibility weighted imaging and quantitative susceptibility mapping: An application to Parkinson's disease. Cheng Z; He N; Huang P; Li Y; Tang R; Sethi SK; Ghassaban K; Yerramsetty KK; Palutla VK; Chen S; Yan F; Haacke EM Neuroimage Clin; 2020; 25():102103. PubMed ID: 31869769 [TBL] [Abstract][Full Text] [Related]
5. Substantia nigra hyperechogenicity and Parkinson's disease risk in patients with essential tremor. Sprenger FS; Wurster I; Seppi K; Stockner H; Scherfler C; Sojer M; Schmidauer C; Berg D; Poewe W Mov Disord; 2016 Apr; 31(4):579-83. PubMed ID: 26893155 [TBL] [Abstract][Full Text] [Related]
6. Neuromelanin-sensitive MRI of the substantia nigra: An imaging biomarker to differentiate essential tremor from tremor-dominant Parkinson's disease. Wang J; Huang Z; Li Y; Ye F; Wang C; Zhang Y; Cheng X; Fei G; Liu K; Zeng M; Zhong C; Jin L Parkinsonism Relat Disord; 2019 Jan; 58():3-8. PubMed ID: 30037690 [TBL] [Abstract][Full Text] [Related]
7. Coronal Transcranial Sonography and M-Mode Tremor Frequency Determination in Parkinson's Disease and Essential Tremor. Richter D; Woitalla D; Muhlack S; Gold R; Tönges L; Krogias C J Neuroimaging; 2017 Sep; 27(5):524-530. PubMed ID: 28426143 [TBL] [Abstract][Full Text] [Related]
8. Simple quantitative planimetric measurement of nigrosome-1 for clinical settings. Chau MT; Agzarian M; Wilcox RA; Dwyer A; Bezak E; Todd G J Neurol Sci; 2023 Nov; 454():120857. PubMed ID: 37939625 [TBL] [Abstract][Full Text] [Related]
10. Nigrosome 1 imaging: technical considerations and clinical applications. Kim EY; Sung YH; Lee J Br J Radiol; 2019 Sep; 92(1101):20180842. PubMed ID: 31067082 [TBL] [Abstract][Full Text] [Related]
11. Nigrosome 1 visibility at susceptibility weighted 7T MRI-A dependable diagnostic marker for Parkinson's disease or merely an inconsistent, age-dependent imaging finding? Gramsch C; Reuter I; Kraff O; Quick HH; Tanislav C; Roessler F; Deuschl C; Forsting M; Schlamann M PLoS One; 2017; 12(10):e0185489. PubMed ID: 29016618 [TBL] [Abstract][Full Text] [Related]
12. Hyperechogenicity of substantia nigra for differential diagnosis of Parkinson's disease: A meta-analysis. Shafieesabet A; Fereshtehnejad SM; Shafieesabet A; Delbari A; Baradaran HR; Postuma RB; Lökk J Parkinsonism Relat Disord; 2017 Sep; 42():1-11. PubMed ID: 28647434 [TBL] [Abstract][Full Text] [Related]
13. Preliminary experience with a transcranial magnetic resonance-guided focused ultrasound surgery system integrated with a 1.5-T MRI unit in a series of patients with essential tremor and Parkinson's disease. Iacopino DG; Gagliardo C; Giugno A; Giammalva GR; Napoli A; Maugeri R; Graziano F; Valentino F; Cosentino G; D'Amelio M; Bartolotta TV; Catalano C; Fierro B; Midiri M; Lagalla R Neurosurg Focus; 2018 Feb; 44(2):E7. PubMed ID: 29385927 [TBL] [Abstract][Full Text] [Related]
14. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Damier P; Hirsch EC; Agid Y; Graybiel AM Brain; 1999 Aug; 122 ( Pt 8)():1437-48. PubMed ID: 10430830 [TBL] [Abstract][Full Text] [Related]
15. The 'swallow tail' appearance of the healthy nigrosome - a new accurate test of Parkinson's disease: a case-control and retrospective cross-sectional MRI study at 3T. Schwarz ST; Afzal M; Morgan PS; Bajaj N; Gowland PA; Auer DP PLoS One; 2014; 9(4):e93814. PubMed ID: 24710392 [TBL] [Abstract][Full Text] [Related]
16. Neuroimaging Assessment of Nigrosome 1 with a Multiecho Gre Magnetic Resonance Sequence in the Differentiation Between Parkinsons Disease from Essential Tremor and Healthy Individuals. Bienes GHAA; Zorzenon CPF; Alves ED; Tibana LAT; Borges V; Carrete H; Ferraz HB Tremor Other Hyperkinet Mov (N Y); 2021 May; 11():17. PubMed ID: 34046247 [TBL] [Abstract][Full Text] [Related]
17. Protocol of a single group prospective observational study on the diagnostic value of 3T susceptibility weighted MRI of nigrosome-1 in patients with parkinsonian symptoms: the N3 Schwarz ST; Xing Y; Naidu S; Birchall J; Skelly R; Perkins A; Evans J; Sare G; Martin-Bastida A; Bajaj N; Gowland P; Piccini P; Auer DP BMJ Open; 2017 Dec; 7(12):e016904. PubMed ID: 29247084 [TBL] [Abstract][Full Text] [Related]
18. Substantia nigra hyperechogenicity in essential tremor and Parkinson's disease: a longitudinal study. Cardaioli G; Ripandelli F; Paolini Paoletti F; Nigro P; Simoni S; Brahimi E; Romoli M; Filidei M; Eusebi P; Calabresi P; Tambasco N Eur J Neurol; 2019 Nov; 26(11):1370-1376. PubMed ID: 31094036 [TBL] [Abstract][Full Text] [Related]
19. Locus coeruleus and substantia nigra neuromelanin magnetic resonance imaging differentiates Parkinson's disease and essential tremor. Wang X; Huang P; Haacke EM; Liu Y; Zhang Y; Jin Z; Li Y; Xu Q; Liu P; Chen S; He N; Yan F Neuroimage Clin; 2023; 38():103420. PubMed ID: 37141646 [TBL] [Abstract][Full Text] [Related]
20. Role of dopamine transporter imaging in the diagnosis of atypical tremor disorders. Marshall V; Grosset DG Mov Disord; 2003 Oct; 18 Suppl 7():S22-7. PubMed ID: 14531042 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]